ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope

This study has been completed.
Sponsor:
Collaborator:
Medtronic
Information provided by:
Medtronic Bakken Research Center
ClinicalTrials.gov Identifier:
NCT00170261
First received: September 12, 2005
Last updated: October 8, 2008
Last verified: October 2008

September 12, 2005
October 8, 2008
April 2002
September 2005   (final data collection date for primary outcome measure)
Cost of diagnostics per patient until final cardiac diagnosis has been made
Cost of diagnostics per patient until final cardiac diagnosos has been made
Complete list of historical versions of study NCT00170261 on ClinicalTrials.gov Archive Site
  • Cost of diagnostics until final diagnosis has been made
  • Rate of correct cardiac diagnoses
  • Comparison of time needed to make a diagnosis
  • Comparison of pre-syncopes and syncopes occuring in both groups after enrollment
Same as current
Not Provided
Not Provided
 
ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope
Early Loop-Recorder in Suspected Arrhythmogenic Syncope

This is a prospective, controlled, opened randomized study to evaluate the cost benefit of a primary implantation of a loop recorder versus the conventional diagnostic cascade for syncope most likely due to cardiac arrhythmia.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Syncope
Device: Use of an Implantable Loop Recorder
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
September 2006
September 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Two or more episodes of syncope (most likely due to cardiac arrhythmia) of uncertain etiology within the last 12 months or more than one syncope and two presyncopes

Exclusion Criteria:

  • Indication for the implantation of a pacemaker
  • Indication for the implantation of an implantable cardioverter defibrillator
  • Cardiac diseases which need intervention (KHK, aortic stenosis, mitral stenosis, left ventricular [LV] outflow stenosis, decompensated heart failure)
  • Contraindication for a diagnostic procedure requested by the study protocol
  • Enrollment in another study
  • Circumstances or comorbidities which do not allow enrollment
Both
18 Years to 85 Years
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00170261
CEN_G_CA_4
Not Provided
Not Provided
Medtronic Bakken Research Center
Medtronic
Principal Investigator: H.-C- Ehlers, MD Vivantes Klinikum am Urban
Medtronic Bakken Research Center
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP